{"title":"贝达喹啉在耐药结核病中的应用：一项小型综述。","authors":"Baljinder Singh, Charan Singh","doi":"10.2174/187446721701240911110426","DOIUrl":null,"url":null,"abstract":"<p><p>In the online version of the article, a change was made in the list of author's and affiliation section. The affiliation of Charan Singh in the online version of the article titled \"Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review\" has been updated in \"Current Molecular Pharmacology,\" 2023; 16: e210422203904 [1]. The original article can be found online at: https://www.eurekaselect.com/article/122759 Original: Baljinder Singh1 1Department of Pharmaceutics, UIPS, Panjab University, Chandigarh 160014, India Corrected: 1Department of Pharmaceutics, UIPS, Punjab University, Chandigarh 160014, India 2Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, 142001, India 3Department of Pharmaceutical Sciences, School of Sciences, Hemvati Nandan Bahuguna Garhwal University (A Central University), Srinagar, Uttarakhand, 246174, India Funding: Original: None. Corrected: The financial support provided by the Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India, under the Research Grant File No. EEQ/2020/000616.</p>","PeriodicalId":93964,"journal":{"name":"Current molecular pharmacology","volume":"17 ","pages":"e110924233920"},"PeriodicalIF":2.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to: Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review.\",\"authors\":\"Baljinder Singh, Charan Singh\",\"doi\":\"10.2174/187446721701240911110426\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In the online version of the article, a change was made in the list of author's and affiliation section. The affiliation of Charan Singh in the online version of the article titled \\\"Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review\\\" has been updated in \\\"Current Molecular Pharmacology,\\\" 2023; 16: e210422203904 [1]. The original article can be found online at: https://www.eurekaselect.com/article/122759 Original: Baljinder Singh1 1Department of Pharmaceutics, UIPS, Panjab University, Chandigarh 160014, India Corrected: 1Department of Pharmaceutics, UIPS, Punjab University, Chandigarh 160014, India 2Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, 142001, India 3Department of Pharmaceutical Sciences, School of Sciences, Hemvati Nandan Bahuguna Garhwal University (A Central University), Srinagar, Uttarakhand, 246174, India Funding: Original: None. Corrected: The financial support provided by the Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India, under the Research Grant File No. EEQ/2020/000616.</p>\",\"PeriodicalId\":93964,\"journal\":{\"name\":\"Current molecular pharmacology\",\"volume\":\"17 \",\"pages\":\"e110924233920\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current molecular pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/187446721701240911110426\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current molecular pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/187446721701240911110426","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在这篇文章的在线版本中，作者列表和隶属关系部分进行了更改。Charan Singh在题为“Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review”的文章网络版中的从属关系已在2023年的“Current Molecular Pharmacology”上更新；[16] e210422203904[1]。原文可在以下网址找到：https://www.eurekaselect.com/article/122759原文：Baljinder sing1 1旁遮普邦大学药学系，印度昌迪加尔1600141旁遮普大学药学研究所药剂学系，昌迪加尔160014 2 ISF药学院药剂学系，旁遮普莫加，142001 3南丹巴胡古纳加尔瓦尔大学（A中央大学）理学院药剂学系，北阿坎德邦斯利那加，246174更正：印度政府科学与技术部科学与工程研究委员会（塞尔维亚）根据研究资助文件（研究资助文件号）提供的财政支持。EEQ / 2020/000616。
Corrigendum to: Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review.
In the online version of the article, a change was made in the list of author's and affiliation section. The affiliation of Charan Singh in the online version of the article titled "Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review" has been updated in "Current Molecular Pharmacology," 2023; 16: e210422203904 [1]. The original article can be found online at: https://www.eurekaselect.com/article/122759 Original: Baljinder Singh1 1Department of Pharmaceutics, UIPS, Panjab University, Chandigarh 160014, India Corrected: 1Department of Pharmaceutics, UIPS, Punjab University, Chandigarh 160014, India 2Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, 142001, India 3Department of Pharmaceutical Sciences, School of Sciences, Hemvati Nandan Bahuguna Garhwal University (A Central University), Srinagar, Uttarakhand, 246174, India Funding: Original: None. Corrected: The financial support provided by the Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India, under the Research Grant File No. EEQ/2020/000616.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
